A rapidly fatal intracranial anaplastic hemangiopericytoma with de-novo dedifferentiation: emphasis on diagnostic recognition, molecular confirmation and discussion on treatment dilemma
Solitary fibrous tumors/ hemangiopericytomas (SFT/HPC) are mesenchymal tumors that share a common genetic aberration and very rarely undergo dedifferentiation. We report a unique case of an intracranial anaplastic SFT/HPC with de-novo dedifferentiation, which pursued a rapidly fatal clinical course in a 41-year-old lady. The dedifferentiated component comprised a focal area of glandular formation with epithelial immunophenotype acquisition. The distinct biphasic pattern of the tumor imparted great diagnostic challenges to the pathologists. An increased awareness of SFT/HPCs with a diverse morphologic spectrum or even a biphasic histologic pattern is essential in working up such cases. We first attempted gamma knife radiosurgery in treating a recurrent dedifferentiated SFT/HPC; unfortunately it was to no avail. Although it is now known that SFT/HPC is characterized by NAB2-STAT6 gene fusion, the unavailability of targeted therapy against this molecular signature still results in a treatment dilemma.
KeywordsSolitary fibrous tumor Hemangiopericytoma STAT6 Intracranial Dedifferentiation Gamma knife
Targeted next generation sequencing and RT-PCR of the tumor were funded by the VIVA-KKH Paediatric Brain and Solid Tumour Programme.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 5.Moritani S, Ichihara S, Hasegawa M, Takada S, Takahashi T, Kato E et al (2010) Dedifferentiation and progression of an intracranial solitary fibrous tumor: autopsy case of a Japanese woman with a history of radiation therapy of the head during infancy. Pathol Int 61:143–149. https://doi.org/10.1111/j.1440-1827.2010.02627.x CrossRefPubMedGoogle Scholar
- 7.Fletcher CDM, World Health Organization, International Agency for Research on Cancer (2013) WHO classification of tumours of soft tissue and bone. World Health Organization classification of tumours, 4th edn. IARC Press, LyonGoogle Scholar
- 16.Nakada S, Minato H, Nojima T (2016) Clinicopathological differences between variants of the NAB2–STAT6 fusion gene in solitary fibrous tumors of the meninges and extra-central nervous system. Brain Tumor Pathol 33Google Scholar
- 17.Chuang IC, Liao K-C, Huang H-Y, Kao Y-C, Li C-F, Huang S-C et al (2016) NAB2-STAT6 gene fusion and STAT6 immunoexpression in extrathoracic solitary fibrous tumors: the association between fusion variants and locations. Pathol Int 66:288–296. https://doi.org/10.1111/pin.12408 CrossRefPubMedGoogle Scholar
- 20.Tai H-C, Chuang IC, Chen T-C, Li C-F, Huang S-C, Kao Y-C et al (2015) NAB2–STAT6 fusion types account for clinicopathological variations in solitary fibrous tumors. Mod Pathol 28:1324. https://doi.org/10.1038/modpathol.2015.90 https://www.nature.com/articles/modpathol201590#supplementary-information. Accessed 16 Sept 2018
- 21.Barthelmeß S, Geddert H, Boltze C, Moskalev EA, Bieg M, Sirbu H et al. (2014) Solitary fibrous tumors/hemangiopericytomas with different variants of the < em> NAB2</em>- STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 184:1209–1218. https://doi.org/10.1016/j.ajpath.2013.12.016 CrossRefPubMedGoogle Scholar
- 24.Dagrada GP, Spagnuolo RD, Mauro V, Tamborini E, Cesana L, Gronchi A et al (2015) Solitary fibrous tumors: loss of chimeric protein expression and genomic instability mark dedifferentiation. Mod Pathol 28:1074. https://doi.org/10.1038/modpathol.2015.70 https://www.nature.com/articles/modpathol201570#supplementary-information. Accessed 25 Sept 2018